Newcleo has appointed Dustin Greenwood as Vice President of U.S. Operations and Travis Chapman as Director of U.S. Regulatory Affairs and Licensing to strengthen its U.S. leadership team. These hires bring extensive experience in nuclear operations, reactor deployment, and regulatory licensing, supporting Newcleo's expansion in the American market. The company aims to advance its lead-cooled fast reactors and mixed-oxide fuel technologies, contributing to clean energy and nuclear waste solutions. Newcleo is also preparing to go public on Nasdaq later in 2026, marking a significant step in its growth strategy.
Evolution Metals & Technologies Corp. has achieved quality certification from two global Tier-1 OEMs for six grades of high-performance sintered NdFeB rare earth magnets produced at commercial scale in Korea. This certification positions EM&T as a cr...
Caribou Biosciences reported that a single dose of their off-the-shelf CB-011 CAR-T cell therapy produced deep and durable responses in heavily pretreated, BCMA-naïve patients with relapsed or refractory multiple myeloma (r/r MM). In a phase 1 trial,...
Indonesia Energy Corporation's President Frank Ingriselli will present an update on the drilling of the K-29 well at the Kruh Block during the Planet MicroCap Conference on June 17, 2026. The company has commenced pre-drilling operations and remains ...
Four artificial intelligence companies are planning to raise more capital than the entire U.S. IPO market has raised over the past five years. This highlights the massive investor interest and growth potential in the AI sector. However, investors are...
OPTA VIA, a coach-guided metabolic health program by Medifast, demonstrated significant clinical results in a 16-week randomized controlled trial. Participants lost 14% visceral fat and retained 98% of lean mass, verified by DXA body composition scan...
